A combination of protein phosphatase 2A inhibition and checkpoint immunotherapy: a perfect storm by Mary C. Clark, Rongze Olivia Lu, Winson S. Ho, Matheus Henrique Dias, René Bernards, Stephen J. Forman

Subjects: Get full text

Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL products by Suzanne M. Castenmiller, Nandhini Kanagasabesan, Aurélie Guislain, Benoît P. Nicolet, Marleen M. van Loenen, Kim Monkhorst, Alexander A.F.A. Veenhof, Egbert F. Smit, Koen J. Hartemink, John B.A.G. Haanen, Rosa de Groot, Monika C. Wolkers

Subjects: Get full text

Integrated microfluidics-based construction of anti-BTN2A2 gel droplet cell preparations for non-invasive tumor-infiltrating lymphocyte therapy by Yishen Tian, Jingxuan Li, Na Yang, Yang Zhao, Jiancao Zuo, Hang Xiong, Yiwen Pan, Li Xiao, Min Su, Feng Han, Zhixu He, Rong Hu

Subjects: Get full text

Adoptive T cell therapy for solid tumors: current landscape and future challenges by Víctor Albarrán, María San Román, Javier Pozas, Jesús Chamorro, Diana Isabel Rosero, Patricia Guerrero, Juan Carlos Calvo, Carlos González, Coral García de Quevedo, Patricia Pérez de Aguado, Jaime Moreno, Alfonso Cortés, Ainara Soria

Subjects: Get full text

Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango? by Mohammad Hossein Kazemi, Mohammad Hossein Kazemi, Maryam Sadri, Maryam Sadri, Alireza Najafi, Alireza Najafi, Ali Rahimi, Ali Rahimi, Zeinab Baghernejadan, Zeinab Baghernejadan, Hossein Khorramdelazad, Reza Falak, Reza Falak

Subjects: Get full text

Modeling ex vivo tumor-infiltrating lymphocyte expansion from established solid malignancies by Hannah M Knochelmann, Amalia M Rivera-Reyes, Megan M Wyatt, Aubrey S Smith, Reilley Chamness, Connor J Dwyer, Michael Bobian, Guillermo O Rangel Rivera, Joshua D Horton, Michael Lilly, Martin J Romeo, Cynthia D Timmers, Mark P Rubinstein, David M Neskey, Chrystal M Paulos

Subjects: Get full text

Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments by S.M. Castenmiller, R. de Groot, A. Guislain, K. Monkhorst, K.J. Hartemink, A.A.F.A. Veenhof, E.F. Smit, J.B.A.G. Haanen, M.C. Wolkers

Subjects: Get full text

Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy by Christopher Aled Chamberlain, Eric Paul Bennett, Anders Handrup Kverneland, Inge Marie Svane, Marco Donia, Özcan Met

Subjects: Get full text

Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study by Magnus Pedersen, Marie Christine Wulff Westergaard, Katy Milne, Morten Nielsen, Troels Holz Borch, Lars Grønlund Poulsen, Helle Westergren Hendel, Mia Kennedy, Gillian Briggs, Stacey Ledoux, Trine Jakobi Nøttrup, Pernille Andersen, Thomas Hasselager, Özcan Met, Brad H. Nelson, Marco Donia, Inge Marie Svane

Subjects: Get full text

Transplanters drive CARs to the clinic by brewing ICE-T: the Moffitt roadmap by Frederick L. Locke, Claudio Anasetti, for the Moffitt Immunotherapy Working Group and the Immune Cell Therapy (ICE-T) Program

Subjects: “…Tumor infiltrating lymphocyte (TIL) therapy…”
Get full text